VNS Therapy™  Global Manuals

These resources are intended for healthcare professionals.

Find out if VNS Therapy® is right for you.

Please select your preferred language from the drop-down menu below.

The most common side effects from stimulation include voice alteration/hoarseness, increased coughing, sore throat, prickling or tingling of the skin, and shortness of breath.

Infection is the most common complication of the procedure.

Epilepsy (EU CE Mark) — The VNS Therapy System is indicated for use as an adjunctive therapy in reducing the frequency of seizures in patients whose epileptic disorder is dominated by partial seizures (with or without secondary generalization) or generalized seizures that are refractory to seizure medications.
Epilepsy (US) — The VNS Therapy System is indicated for use as an adjunctive therapy in reducing the frequency of seizures in patients 4 years of age and older with partial onset seizures that are refractory to antiepileptic medications.

Not approved in all geographies. Indications for use vary by region.

Contact Us

Customer Support

phone 1-866-332-1375

(If you are an implanted patient and need a replacement VNS Therapy Patient Emergency Information Card, please contact Customer Support)

Clinical Technical Services

phone US: +1-866-882-8804

phone International: +32-2-790-27-73

(Physicians of implanted patients can contact Clinical Technical Services regarding technical concerns)

Patients needing additional magnets should contact their physicians. Patients and caregivers of implanted patients should contact their physicians with technical concerns.

LivaNova Belgium NV
Ikaroslaan 83
1930 Zaventem
Belgium
Tel: +32.2.720.95.93
Fax: +32.2.720.60.53
LIVANOVA PLC
Mfg by LivaNova USA, Inc
100 Cyberonics Boulevard
Houston, Texas 77058
Tel: +1.800.332.1375
Fax: +1.281.218.9332
UK: 0800 0461355
EU: +32 2 790 27 73
www.LivaNova.com